Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial.
BACKGROUND: Obstructive sleep apnoea syndrome (OSAS) has been associated with cardiovascular disease in epidemiological and observational studies. Continuous positive airway pressure (CPAP) is the treatment of choice for OSAS, but the impact of this intervention on systemic inflammation involved in...
Main Authors: | Kohler, M, Ayers, L, Pepperell, J, Packwood, K, Ferry, B, Crosthwaite, N, Craig, S, Siccoli, M, Davies, R, Stradling, JR |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Continuous positive airway pressure treatment for obstructive sleep apnoea reduces resting heart rate but does not affect dysrhythmias: a randomised controlled trial.
by: Craig, S, et al.
Published: (2009) -
Baroreflex sensitivity increases after 4 weeks of nasal continuous positive airway presure therapy in patients with obstructive sleep apnoea
by: Pepperell, J, et al.
Published: (2001) -
Blood pressure change after treatment for obstructive sleep apnoea (OSA) with continuous positive airway pressure (CPAP)
by: Pepperell, J, et al.
Published: (2000) -
Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.
by: Pepperell, J, et al.
Published: (2002) -
Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial.
by: Siccoli, M, et al.
Published: (2008)